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S
pinal cord injury (SCI) has 
been recognized as one of the 
conditions for which stem cell 
transplantation might ﬁ  rst prove 
beneﬁ  cial [1]. After SCI, loss of 
localized myelinating oligodendrocytes 
and grey matter neurons occurs, 
with glial scar formation and 
degeneration of both descending 
and ascending axons (Figure 1). 
Replacement of oligodendrocytes 
to promote remyelination or of 
neurons to assuage neuronal loss and 
damage through establishment of 
relay circuitry or release of trophic 
factors, are possibilities for stem 
cell transplantation intervention. 
Scientists and clinicians recognize 
the need to move cautiously toward 
cell replacement goals, as damaging 
results due to premature clinical testing 
would be devastating for patients and 
the emerging stem cell neural repair 
ﬁ  eld. Animal studies need to address 
fundamental questions—Which is 
the best cell source for neuron or 
oligodendrocyte replacement, what is 
the best location for transplantation, 
and what is the best time-course after 
injury? 
Embryonic Spinal Cord Stem Cells 
Are Closest to the Goalpost
Embryonic stem cells can be pushed 
to generate cells with characteristics 
of spinal cord neurons and 
oligodendrocytes, and studies are 
ongoing to establish the breadth 
of spinal cord cell types that can be 
produced, their long-term stability, and 
their functional authenticity. Another 
stem cell source that is being pursued, 
and that may in fact be closer to the 
goal of producing a variety of bone ﬁ  de 
spinal cord cells, is stem cells from the 
spinal cord itself. These are a subclass 
of neural stem cells (NSCs) and as such 
are restricted to generating neural 
tissues, which is a notable advantage 
over embryonic stem cells, and have the 
further advantage of being regionally 
speciﬁ  ed to produce spinal cord 
progeny. Stem cells can be isolated 
from spinal cord from embryonic 
through adult stages [2–4]; however, 
early embryonic stages most readily 
generate a wide array of spinal cord 
neurons and glia: NSCs restrict their 
developmental potency over time, and 
unfortunately we do not currently know 
how to reverse the NSC aging process.
Stem Cells Used for SCI 
A recent terriﬁ  c review [5] summarizes 
the state of stem cell transplantation 
for SCI. Previous studies on implanting 
embryonic NSCs after SCI show that 
these cells can make oligodendrocytes 
effectively in vivo; however, neuron 
production is notably poor. These 
results have led to the idea that the 
adult SCI environment does not 
allow NSCs to differentiate efﬁ  ciently 
into neurons. Starting with a more 
differentiated cell population such 
as NRPs—restricted progenitors for 
neurons—allows neuron production 
[6–8], perhaps because these cells no 
longer need environmental instruction 
to attain the neuronal fate. While, 
GRPs—restricted progenitors for 
glia—and NRPs could be valuable for 
producing speciﬁ  c types of progeny, 
it is still appealing to consider use of 
NSCs that could, in theory, generate 
a wider variety of neurons and glia, 
potentially tailoring output according 
to the speciﬁ  c cell needs of an 
individual SCI situation. Hence, it is 
somewhat disappointing that prior NSC 
studies have not led to more neuron 
production in vivo. However, it is 
important to realize that of the prior 
NSC SCI studies (approximately 30), 
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Figure 1. Normal and Injured Spinal Cord
(A) Normal spinal cord with examples of ascending (green) and descending (red) pathways. 
(B) After SCI, degeneration of both descending and ascending axons occurs with glial scar 
formation and loss of local myelinating oligodendrocytes and grey matter neurons. Stem cells 
could provide growth factors beneﬁ  cial to SCI repair, or help replace lost myelin or circuitry.PLoS Medicine  |  www.plosmedicine.org 0237
most actually used brain NSCs. Only 
three used NSCs from embryonic spinal 
cord, two from rat [9,10], and one 
from human [3]. When we consider 
the dearth of spinal cord NSC studies, 
especially in humans, it is perhaps 
premature to view the adult injured 
cord as lacking crucial differentiation 
instructions.
Filling the Gap with Human Spinal 
Cord Stem Cells
The need for human spinal cord 
stem cell studies alone makes the 
paper by Yan et al. [11] an important 
contribution. Moreover, it is the 
ﬁ  rst to assess the potential of human 
embryonic spinal cord cells expanded 
in adherent rather than neurosphere 
culture. Most of the prior NSC studies 
used cells expanded using neurosphere 
generation, in which nonadherent 
cells proliferate to form multicell 
spheres. This is a standard method for 
propagating stem cells [12,13], but only 
very few cells can proliferate under these 
conditions, and this technique might 
select for a particular subpopulation 
(and potentially a gliogenic 
subpopulation) of stem cells [14]. In 
contrast, adherent culture allows growth 
of a larger and more heterogeneous 
population of starting cells (Figure 2) 
[15,16], as well as providing different 
surface signaling during the expansion 
phase that could well impact subsequent 
cell behavior. Here Yan et al. investigate 
the fate of adherent cultured human 
embryonic spinal cord stem cells in an 
adult SCI environment. 
Spinal cord cells were obtained from 
cervical and upper thoracic spinal cord 
of an eight-week-old human embryo 
and expanded in monolayer culture 
in deﬁ  ned medium with the mitogen 
FGF2 (a member of the ﬁ  broblast 
growth factor family). They could be 
propagated for at least 20 passages 
and frozen and thawed with good 
recovery. Most of the cells expressed 
the progenitor marker Nestin, but 
upon withdrawal of FGF2, the cells 
differentiated, and approximately 
50% became neurons (expressing 
the neuronal marker MAP2). Cells 
in differentiated cultures expressed 
neurotrophic factors and neuregulins, 
indicating that they could produce 
potentially useful agents for SCI.
Two types of injury were examined: 
extraspinal avulsion of L4 and L5 
spinal nerves, and excititoxic lesion at 
the L4–L5 levels. Passage 10–12 cells 
were used in the study and FGF2 was 
removed from the culture up to 24 h 
before the cells were transplanted. Two 
weeks postlesion, animals received four 
injections of 105 spinal cord stem cells, 
each in 0.5 ml suspension, into ventral 
L4 and L5 on the left side 1 mm lateral 
to the midline. 
Abundant Human Neuron 
Production in the Adult Spinal Cord
The implanted cells showed robust 
engraftment and good long-term 
survival. NSCs migrated away from 
the initial grafting sites and populated 
both white and gray matter, as well as 
portions of dorsal roots in avulsion 
cases. 3%–5% of cells remained 
mitotically active (i.e., were positive for 
the proliferating cell marker Ki67). 
Most surprising was the ﬁ  nding that 
over 70% of cells in dorsal or ventral 
horn of L4–L5 expressed the neuronal 
marker TUJ1. 11%–14% of the cells 
were Nestin positive, and only 5% 
expressed the astrocyte marker GFAP. 
Of cells residing in white matter, 
approximately 60% were neurons 
and 16%–20% were positive for the 
astroglial marker GFAP. Very few cells 
became oligodendrocytes (9% in grey 
matter and 12% in white matter). 
The authors further deﬁ  ned the 
neuronal phenotypes with extensive 
immunoanalysis. Many expressed the 
more mature marker NeuN, and most 
developed GABAergic phenotypes (see 
Box 1 for glossary). Moreover, these 
cells were contacted by GABAergic 
terminals from graft and host neurons 
Glossary
ChAT: Choline acetyl transferase, present 
in motor neurons
GABAergic: A marker indicative of 
inhibitory neurons
GFAP: A marker of astrocytes also 
expressed by some NSCs
GRP: Restricted progenitor for glia
Nestin: A marker of progenitor cells
NeuN: A nuclear marker of more mature 
neurons expressed by many neuron 
types
NRP: Restricted progenitor for neurons 
NSC: Multipotent, self-renewing cell 
producing neurons and glia, but not non-
neural cells
TUJ1: An early marker of neurons
doi:10.1371/journal.pmed.0040048.g002
Figure 2. Spinal Cord Progenitors Isolated from the Cord and Grown in Tissue Culture as 
Adherent Cultures or Nonadherent Nanospheres
More heterogeneity is seen after adherent culture compared to neurosphere culture.
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and glutamatergic terminals from the 
host. Less than 1% of cells were ChAT 
positive, indicating little motor neuron 
generation. There is evidence for 
process outgrowth from the engrafted 
neurons, and for synaptic connections 
with host motor neurons.
To our knowledge this study is the 
ﬁ  rst to show that adult human spinal 
cord stem cells can be expanded in 
adherent culture without genetic 
modiﬁ  cation to generate large numbers 
of cells sufﬁ  cient for transplantation, 
and the ﬁ  rst NSC study to ﬁ  nd 
signiﬁ  cant neuron generation in the 
injured adult spinal cord. The authors 
conclude that the adult spinal cord 
environment can in fact encourage 
spinal cord stem cells to make new 
neurons efﬁ  ciently. This study also 
indicates that differences in the culture 
technique, such as the cell expansion 
method, can have a major impact on 
NSC behavior after transplantation. 
Future Studies
The production of so many neurons 
in the adult in vivo reported here has 
been an elusive goal of stem cell studies 
for years. Given the signiﬁ  cance of this 
ﬁ  nding, it will be critical to verify that 
these cells are bone ﬁ  de functional 
neurons using electrophysiological 
recording, beyond the use of 
immunomarkers described in the paper. 
It will also be crucial to repeat this work 
using different primary lines established 
from human embryonic spinal cord. If 
this result is veriﬁ  ed, then future studies 
should investigate whether diverse 
subtypes of spinal cord neurons, such as 
motor neurons, can be produced—for 
example, if an earlier embryonic 
spinal cord source is used, or if the 
cells are treated with growth factors 
such as Shh prior to transplantation—
generating large quantities of motor 
neurons will be beneﬁ  cial for treating 
neurodegenerative diseases such as 
ALS (amyotrophic lateral sclerosis). 
It will also be important to determine 
whether signiﬁ  cant neuron production 
is obtained after other experimental 
types of SCI—e.g., the contusion 
model [17]—which create the type of 
injuries closer physiologically to those 
typically seen in human patients [18]. 
Additionally, it should be noted that 
to study the behavior of human cells 
in the rat experimental SCI models, 
the authors had to immunosuppress 
the animals or use nude hosts. Since 
SCI in rodents is usually accompanied 
by substantial inﬂ  ammation, the use 
of immunosuppressed animals is not a 
perfect model for study of transplanted 
cell behavior. This, however, is a general 
problem encountered when studying 
the behavior of human cells in animal 
models. It seems unlikely that effective 
neuron production could have resulted 
from immunosuppression, but that 
is certainly something that could be 
examined. Finally, since behavioral 
improvement is the ultimate measure 
of the success of the transplantation 
treatment, further studies should 
include behavioral analysis of the 
experimental subjects.  
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